BioMaxima S.A. (WSE:BMX)
Poland · Delayed Price · Currency is PLN 8.93
-0.37 (-3.98%)
Nov 4, 2026, 4:59 PM CET
BioMaxima Ratios and Metrics
Market cap in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 37 | 51 | 45 | 69 | 106 | 114 | |
Market Cap Growth | -31.04% | 12.62% | -34.84% | -35.28% | -6.37% | -4.71% |
Enterprise Value | 53 | 65 | 56 | 76 | 95 | 122 |
Last Close Price | 9.30 | 12.05 | 10.70 | 16.42 | 25.16 | 25.27 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 46.29 | 481.21 | 83.86 | 117.49 | 3.68 | 11.09 |
PS Ratio | 0.64 | 0.83 | 0.85 | 1.47 | 0.74 | 1.44 |
PB Ratio | 0.81 | 1.05 | 0.95 | 1.47 | 2.03 | 3.89 |
P/TBV Ratio | 0.82 | 1.06 | 0.95 | 1.48 | 2.05 | 3.96 |
P/FCF Ratio | 31.20 | 21.28 | - | - | 3.91 | - |
P/OCF Ratio | 19.38 | 14.98 | - | 43.25 | 2.87 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.90 | 1.07 | 1.06 | 1.64 | 0.66 | 1.54 |
EV/EBITDA Ratio | 10.53 | 16.37 | 13.08 | 32.69 | 2.58 | 8.06 |
EV/EBIT Ratio | 38.52 | 59.12 | 44.05 | 1141.79 | 2.71 | 8.91 |
EV/FCF Ratio | 43.58 | 27.53 | - | - | 3.48 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.35 | 0.30 | 0.31 | 0.27 | 0.11 | 0.59 |
Debt / EBITDA Ratio | 3.22 | 3.05 | 3.20 | 5.17 | 0.16 | 1.13 |
Debt / FCF Ratio | 13.34 | 6.09 | - | - | 0.21 | - |
Net Debt / Equity Ratio | 0.32 | 0.27 | 0.29 | 0.24 | -0.13 | 0.49 |
Net Debt / EBITDA Ratio | 3.49 | 3.18 | 3.20 | 4.85 | -0.19 | 0.95 |
Net Debt / FCF Ratio | 12.38 | 5.36 | -5.66 | -0.69 | -0.26 | -3.09 |
Asset Turnover | 0.77 | 0.79 | 0.70 | 0.63 | 2.11 | 1.44 |
Inventory Turnover | 2.23 | 2.39 | 2.11 | 1.96 | 6.55 | 3.70 |
Quick Ratio | 0.77 | 0.83 | 0.70 | 0.96 | 2.13 | 1.13 |
Current Ratio | 1.52 | 1.74 | 1.49 | 2.19 | 3.30 | 1.93 |
Return on Equity (ROE) | 1.69% | 0.22% | 1.14% | 1.18% | 70.75% | 41.74% |
Return on Assets (ROA) | 1.12% | 0.90% | 1.06% | 0.06% | 32.00% | 15.57% |
Return on Invested Capital (ROIC) | 1.83% | 1.01% | 2.14% | 0.13% | 63.29% | 30.67% |
Return on Capital Employed (ROCE) | 2.30% | 1.80% | 2.20% | 0.10% | 55.00% | 30.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.16% | 0.21% | 1.19% | 0.85% | 27.15% | 9.01% |
FCF Yield | 3.21% | 4.70% | -5.40% | -23.95% | 25.55% | -4.06% |
Dividend Yield | - | - | - | - | 1.95% | 1.71% |
Payout Ratio | - | - | - | 357.85% | 6.74% | 10.71% |
Buyback Yield / Dilution | - | - | 2.89% | 3.16% | 0.52% | -4.45% |
Total Shareholder Return | - | - | 2.89% | 3.16% | 2.47% | -2.73% |